UK MHRA Awards Bluebird’s LentiGlobin An Innovation Passport
Bluebird Is Calling On Companies To Share Experiences Of ILAP
Companies that are in earlier stages of the drug development process will benefit most from the UK regulator's new pathway for innovative medicines.
